BNP/PUT/INTUITIVE SURGICAL/400/0.1/19.12.25 Share Price

Warrant

DE000PC1FYR9

Real-time Boerse Frankfurt Warrants 09:20:39 27/06/2024 pm IST
3.78 EUR +1.34% Intraday chart for BNP/PUT/INTUITIVE SURGICAL/400/0.1/19.12.25
Current month-24.95%
1 month-22.93%
Date Price Change
27/24/27 3.78 +1.34%
26/24/26 3.73 +0.54%
25/24/25 3.71 -7.48%
24/24/24 4.01 +2.56%
21/24/21 3.91 -3.22%

Real-time Boerse Frankfurt Warrants

Last update June 27, 2024 at 09:20 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1FYR
ISINDE000PC1FYR9
Date issued 08/12/2023
Strike 400 $
Maturity 19/12/2025 (540 Days)
Parity 10 : 1
Emission price 8.36
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 9.82
Lowest since issue 3.67
Delta-0.27x
Omega 2.932
Premium18.44x
Gearing10.88x
Moneyness 0.9075
Difference Strike -42.07 $
Difference Strike %-10.52%
Spread 0.01
Spread %0.26%
Theoretical value 3.785
Implied Volatility 35.94 %
Total Loss Probability 57.03 %
Intrinsic value 0.000000
Present value 3.785
Break even 359.48 €
Theta-0.02x
Vega0.17x
Rho-0.22x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
442.6 USD
Average target price
426.5 USD
Spread / Average Target
-3.63%
Consensus